Jacobs Levy Equity Management, Inc Chemo Centryx, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $166,845 - $968,974	-24,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$6.47 - $8.96 $267,793 - $370,854	-41,390 Reduced 62.82%	24,500 $166,000
Q2 2019 Aug 13, 2019	BUY	$8.31 - $14.85 $122,157 - $218,295	14,700 Added 28.72%	65,890 $613,000
Q1 2019 May 14, 2019	BUY	$10.01 - $13.89 $512,411 - $711,029	51,190 New	51,190 $711,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $383,458 - $513,792	-41,908 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $18,882 - $24,696	-1,800 Reduced 4.12%	41,908 $530,000
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $297,360 - $391,440	28,000 Added 178.25%	43,708 $576,000
Q1 2018 May 15, 2018	SELL	$5.9 - $14.99 $112,690 - $286,309	-19,100 Reduced 54.87%	15,708 $214,000
Q4 2017 Feb 13, 2018	SELL	$5.53 - $8.42 $469,568 - $714,967	-84,913 Reduced 70.93%	34,808 $207,000
Q3 2017 Nov 14, 2017	SELL	$6.5 - $10.69 $40,943 - $67,336	-6,299 Reduced 5.0%	119,721 $888,000
Q2 2017 Nov 09, 2017	BUY	N/A	126,020	126,020 $1.18 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.